Context: Overweight and obese children have an increased risk to develop cardiovascular diseases (CVDs) in which thyroid-stimulating hormone (TSH) has been suggested as an intermediary factor. However, results of cross-sectional studies are inconclusive, and intervention studies investigating changes in TSH concentrations in association with changes in cardiovascular risk parameters in overweight and obese children are scarce.
I
t is indisputable that overweight and obese children are characterized by an elevated cardiovascular risk profile (1) (2) (3) (4) . Various well-known factors associated with overweight and obesity such as dyslipidaemia, high blood pressure (BP), and decreased insulin sensitivity are associated with low-grade inflammation and oxidative stress, ultimately altogether leading to endothelial dysfunction (5) . It has been suggested that thyroid-stimulating hormone (TSH) is an additional intermediary factor involved in the pathogenesis of cardiovascular diseases (CVDs). However, results of previous studies evaluating associations between cardiovascular risk parameters and TSH concentrations are inconclusive. Both in children and adults with a normal weight, overweight, and obesity, positive associations between TSH concentrations and cardiovascular risk parameters, including total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triacylglycerol (TAG) concentrations, and insulin sensitivity, have been found (6) (7) (8) (9) (10) (11) (12) (13) . Not all studies were able to show these associations in overweight and obese children (14, 15) . Furthermore, TSH concentrations in the high normal range or above the normal range are common in overweight and obese children and are often higher compared with TSH concentrations of normal-weight children (9, 12) . Different underlying mechanisms have been postulated trying to explain these frequently found high normal TSH concentrations, including leptin-mediated production of prothyrotropinreleasing hormone and thyroid hormone resistance (16) (17) (18) . In addition, we recently demonstrated that TSH release by the pituitary in response to TRH stimulation might be an important contributing factor to high circulating TSH concentrations, but it remains so far unknown if pituitary TSH release is involved in modulating cardiovascular risk parameters (19) .
Some studies showed that moderately elevated TSH concentrations normalized after weight loss in obese children and demonstrated an association between changes in TSH concentrations and changes in body weight (14, 15) . However, results are far from conclusive because a substantial number of other studies found no associations between changes in TSH concentrations and changes in body weight or body composition after a lifestyle intervention (6, 8, 13, 20) . Although the association between changes in TSH concentrations and changes in body weight is extensively studied in overweight and obese children, there is only limited insight into the associations between changes in TSH concentrations and changes in cardiovascular risk parameters (6, 8) . Therefore, the aim of the current study was to evaluate the associations of TSH concentrations with cardiovascular risk parameters, as well as the associations between changes in TSH concentrations and changes in cardiovascular risk parameters in euthyroid overweight and (morbidly) obese children, before and after 12-month lifestyle intervention. Furthermore, we evaluated whether TSH release by the pituitary in response to exogenous TRH stimulation was associated with increased CVD.
Methods

Setting
This study was designed and conducted within the setting of the Centre for Overweight Adolescent and Children's Health Care (COACH) at the Maastricht University Medical Centre. Within COACH, the health status of overweight and (morbidly) obese children was evaluated, and children were monitored and guided as described previously (4) . Briefly, participation in the COACH program started with a comprehensive assessment aimed to exclude underlying syndromic or endocrine conditions of being overweight, to evaluate complications and risk factors, and to gain insight into behavior and (family) functioning. After the assessment, all children and their families were offered ongoing, tailored, and individual guidance with focus on lifestyle changes on a frequent basis at the outpatient clinic. Issues that were recognized during the assessment as possibilities for improvement in lifestyle determined the individual accents and priorities during the treatment. The behavioral change strategies used were motivational interviewing, goal setting, positive reinforcement, social support, and relapse prevention. By focusing on small, step-by-step lifestyle improvements, the program aimed to convert the lifestyle changes to daily habits meant to become permanent (4) . Furthermore, participation in sports activities in groups and activities aimed at increasing nutritional knowledge was offered. A follow-up assessment including all the examinations performed during the initial assessment was offered annually to all children. Due to a continuous inflow of children in the program, the moment of inclusion and therefore the duration of the follow-up time differed for each child (4).
Study participants
In total, 369 children who started participating in the COACH program were considered for inclusion in these analyses. Children with TSH concentrations above the normal range were excluded from this study (11%, n = 39). Finally, 330 children with baseline TSH concentrations within the normal range were eligible for inclusion. In a subgroup (n = 73) of these 330 euthyroid children, an additional thyrotropin-releasing hormone (TRH) stimulation test was performed to evaluate TSH release by the pituitary in response to exogenous TRH stimulation.
The effect of the lifestyle intervention on thyroid functioning and the potential association with changes in cardiovascular risk parameters were evaluated in 99 children in whom a clinical reassessment was conducted again after 1 year of intervention. This study was conducted according to the guidelines laid down in the Declaration of Helsinki and approved by the medical ethical committee of the Maastricht University Medical Centre. Subsequently informed consent was obtained.
Anthropometric characteristics
Anthropometric data were obtained while children were barefoot and wearing only underwear. Body weight was determined using a digital scale (Seca), and body length was measured using a digital stadiometer. Body mass index (BMI) was calculated, and BMI z scores were obtained using a growth analyzer (Growth Analyzer VE). To evaluate the effect of the intervention on weight, changes in BMI z score were used. The BMI z score reflects a measure of weight, adjusted for height, sex, and age. Based on the International Obesity Task Force criteria, children were classified as overweight, obese, or morbidly obese (21) , corresponding to the 90th, 99th, and 99.8th percentile, respectively. Waist circumference was measured with a nonelastic tape at the end of a natural breath at midpoint between the top of the iliac crest and the lower margin of the last palpable rib. Hip circumference was measured at the widest portion of the buttocks. Waist and hip circumference z scores were determined (22) , waist-to-hip ratio was calculated, and ethnicity was defined (23) .
Thyroid function
Venous blood samples were collected after a minimum of 8 hours' overnight fasting for analyzing baseline serum TSH (Cobas 8000 Modular Analyzer; Roche) and free thyroxine (fT4) concentrations (Autodelfia Fluoroimmunoassay System; PerkinElmer). TSH concentrations were considered within the normal range based on age-specific reference ranges (24) . Moreover, fT4 concentrations between 8 and 18 pmol/L were considered normal. In a subgroup of children (n = 73), a TRH stimulation test was performed as described previously (19) . TSH release in response to exogenous TRH stimulation was assessed. TSH concentrations 20 minutes after TRH administration (t 20 ) and TSH incremental area under the curve (iAUC) during the TRH stimulation test were used as measures for pituitary response to TRH (19) .
Cardiovascular risk parameters
In all 330 children, a fasting lipid and lipoprotein profile, including serum TC, LDL-C, HDL cholesterol, and TAG concentrations, was measured at baseline (Cobas 8000 Modular Analyzer; Roche). was measured (Multi Spot ELISA Assay; Meso Scale Discovery) in a subgroup (n = 234). This subgroup included all children in whom the panel was measured at the time of this study in the sample set coming from the clinical care line. Fasting plasma glucose (Cobas 8000 Modular Analyzer; Roche), serum insulin (Immulite-1000; Siemens Health Care Diagnostics), and hemoglobin A1c (HbA1c) concentrations (HPLC Variant II; Bio-Rad Laboratories) were measured. Insulin sensitivity was estimated by calculation of the homeostatic model assessment of insulin resistance (HOMA-IR) (25) . HOMA-IR is a simple, inexpensive substitute for insulin sensitivity derived from a mathematical assessment of the balance between hepatic glucose output and insulin secretion, for which only fasting plasma glucose and fasting serum insulin are required. The following formula was used: fasting glucose (mmol/L) 3 fasting insulin (mU/L)/22.5 (25) . Daytime BP was measured during a period of 1.5 hours for approximately 20 times with an interval of 3 minutes between each measurement using the Mobil-O-Graph (I.E.M. GmbH). Mean BP was calculated based on these 20 measurements. The size of the cuff used corresponded with the circumference of the upper arm. Systolic BP (SBP) and diastolic BP (DBP) z scores were calculated according to reference values related to height and sex (26) . All cardiovascular risk parameters as described previously were also measured after 1 year of intervention in the 99 children in whom a clinical reassessment was conducted.
Statistical analysis
All statistical analyses were performed using SPSS 23.0 for Windows (SPSS Inc.). Shapiro-Wilk test was performed to test for normality. Differences in baseline characteristics between groups were analyzed with a x 2 test, Student t test, or MannWhitney U test, as appropriate. The TSH iAUC during the TRH stimulation test was calculated using the trapezoidal method. BMI z score and cardiovascular risk parameters before and after the intervention were compared using the paired Student t test or the Wilcoxon signed-rank test, as appropriate. Associations between variables were determined by linear regressions models. Because TSH concentrations are age dependent (24) , all associations were adjusted for age. Log transformation was used for TSH variables to minimize the effect of outliers on the results. A P value , 0.05 was considered statistically significant. Data are presented as mean with standard deviation (SD) or as median with the minimum and maximum.
Results
Participant characteristics
Three hundred and thirty euthyroid children (43% boys) with a median age of 12.0 (2.6 to 18.9) years were enrolled. Twenty percent were overweight (n = 66), 45% were obese (n = 148), and 35% were morbidly obese (n = 115). Baseline characteristics for the complete group stratified by weight status category are presented in Table 1 . Several cardiovascular risk factors, including serum LDL-C and C-reactive protein concentrations, HOMA-IR, and DBP were higher in the morbidly obese children as compared with overweight and obese children ( Table 1) .
The median baseline serum TSH concentration was 2.6 (0.8 to 5.6) mU/L, and the median serum fT4 concentration was 12.9 (8.2. to 19.6) pmol/L. There was no significant association between baseline serum TSH and fT4 concentrations. Both serum TSH and fT4 concentrations did not differ significantly between the three weight status categories (Table 1) . Serum TSH concentrations at t 20 as well as TSH iAUC were both positively associated with baseline serum TSH concentrations (r 2 = 0.484, P , 0.001; r 2 = 0.307, P # 0.001, respectively).
Associations between TSH and cardiovascular risk parameters at baseline Linear regression analysis adjusted for age showed no association between baseline serum TSH concentrations and baseline BMI z score. Positive associations were found for serum TSH concentrations and serum TC concentrations (r 2 = 0.053, P = 0.006), LDL-C concentrations (r 2 = 0.058, P = 0.002), TAG concentrations (r 2 = 0.056, P = 0.003), and MCP-1 concentrations (r 2 = 0.055, P = 0.017) at baseline ( Table 2) . Effects were specific for TSH because serum fT4 concentrations were not associated with lipid and lipoprotein concentrations or with markers reflecting proinflammatory status and endothelial dysfunction. Furthermore, serum C-reactive protein and IL-6 concentrations showed significant inverse associations with TSH concentrations at t 20 (r 2 = 0.142, Associations between changes in TSH and cardiovascular risk parameters after 12-month lifestyle intervention In the 99 children who were reassessed after a 1-year lifestyle intervention, BMI z score was significantly decreased by 0.16 6 0.35 units. The majority of the children (63%, n = 62) showed a successful decrease in BMI z score, with a mean change of -0.35 6 0.27 units in this subgroup (Table 3 ). In the subgroup of children with an increase in BMI z score (37%, n = 37) after 1-year intervention, the BMI z score increased by 0.17 6 0.15 units. At baseline, children with a successful decrease in BMI z score were significantly younger (P , 0.001), had Data presented as mean 6 SD or as median (minimum to maximum); children were classified as overweight, obese, or morbidly obese based on the International Obesity Task Force criteria (21) . a Significant difference between weight status categories, P , 0.01.
b Statistically different between overweight, obese, and morbidly obese children, P , 0.0167.
c Statistically different between overweight and obese children, P , 0.0167.
d Statistically different between overweight and morbidly obese children, P , 0.0167.
e Statistically different between obese and morbidly obese children, P , 0.016.
f Significant difference between weight status categories, P , 0.05.
g MCP-1, IL-6, IL-8, ICAM-1, and VCAM-1 were measured in a subgroup (total group, N = 234; overweight, n = 42; obese, n = 112; morbidly obese, n = 80).
lower waist and hip circumference z scores (P = 0.039, P = 0.032, respectively), lower insulin concentrations (P = 0.030), and a lower HOMA-IR (P = 0.047), as compared with children with an increase in BMI z score. Importantly, in the complete group, several cardiovascular risk parameters reduced significantly after the first year of the intervention, including serum TC concentrations (P = 0.016), LDL-C concentrations (P = 0.005), HbA1c concentrations (P , 0.001), ICAM-1 concentrations (P , 0.001), and DBP (P = 0.044) ( Table 3) . Although changes in these cardiovascular risk parameters were not associated with change in BMI z score, significant improvements were predominantly present in children with a decrease in BMI z score and not in children with an increase in BMI z score (Table 3) . Interestingly, changes in serum TSH concentrations after the lifestyle intervention were positively associated with changes in serum TC concentrations (r 2 = 0.073, P = 0.007) and changes in serum TAG concentrations (r 2 = 0.061, P = 0.018) (Table 4) . When stratified for changes in BMI z score (e.g., decrease or increase), associations between changes in serum TSH concentrations and changes in cardiovascular risk parameters were only significant in the children with a decrease in BMI z score (Table 4) . Serum TSH concentrations did not change significantly after 1-year lifestyle intervention in the complete group (P = 0.324), nor in the subgroups of children with a decrease in BMI z score (P = 0.267) and with an increase in BMI z score (P = 0.813) ( Table 3) .
Discussion
This study is unique for demonstrating associations between a wide variety of cardiovascular risk parameters and serum TSH concentrations in euthyroid overweight and (morbidly) obese children. These associations were specific for TSH concentrations and not apparent for fT4 concentrations. The results of this study further illustrate that an ongoing, tailored, outpatient lifestyle intervention is effective in improvement of cardiovascular risk parameters. Interestingly, changes in these risk parameters (serum TC, LDL-C, and TAG concentrations) were significantly associated with changes in serum TSH concentrations, clearly strengthening earlier suggestions of an intermediary role for TSH. Several hypotheses can be postulated about the interaction between serum TSH concentrations and cholesterol metabolism and the underlying mechanisms. Previous studies demonstrated that TSH receptors (TSHr) are not merely expressed in thyroid tissue, but also in other tissues, including hepatocytes (27) . TSH binding to hepatic TSH-r stimulates sterol regulatory elementbinding proteins (SREBP-2) and consequently transcription of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase, which leads to higher endogenous cholesterol synthesis (28, 29) . Furthermore, TSH-r activation lowers bile acid synthesis. In healthy subjects and rodents, it was shown that TSH represses the SREPB-2/HNF-4a/ CYP7A1 signaling pathway, resulting in decreased bile acid synthesis making a lower LDL-C uptake from the circulation necessary (30) . In addition, an inverse association between TSH concentrations and serum total bile acid concentrations was demonstrated in adults with subclinical hypothyroidism (31) . Finally, TSH increases proprotein convertase subtilisin kexin type 9 (PCSK9) transcription, another SREBP-2 target. PCSK9 is considered an important regulator of LDL-receptor (LDL-r) function by inhibiting LDL-r recycling to the cell surface (32) . Recently Ozkan et al. demonstrated a positive association between PCSK9 and TSH concentrations (33) , which suggests that there might also be an effect of TSH on LDL-r function, mediated via PCSK9. In our study, we observed significant associations, but the design of the study did not allow us to show causality of TSH in regulating serum cholesterol concentrations. Therefore, the inverse possibility that elevated LDL-C concentrations stimulated the pituitary to increased TSH secretion should also be considered. However, this is unlikely because no indications for abnormal TSH concentrations have been reported, for example, in children with elevated serum cholesterol concentrations, such as evident in familial hypercholesterolemia. Because a wide variety of factors are involved in cholesterol metabolism and modulation, there may also be other explanations for our findings. Given the clear associations at baseline as well as with the changes during the lifestyle intervention between serum TSH and lipoprotein concentrations, a more indepth analysis regarding the potential association between TSH and whole-body cholesterol metabolism seems interesting. There is a remarkable lack of knowledge regarding the potential role of TSH on whole-body endogenous cholesterol synthesis, intestinal cholesterol absorption, hepatic very-low-density lipoprotein synthesis, and receptor-mediated cholesterol clearance in vivo in humans.
Because results of our previous study suggested that TSH release by the pituitary in response to exogenous TRH stimulation might be an important factor contributing to high normal serum TSH concentrations (19) , the question emerged whether the level of pituitary TSH release is involved in modulating cardiovascular risk parameters, or if the associations between TSH and cardiovascular risk parameters are primarily the effect of circulating serum TSH concentrations. Neither TSH concentrations at t 20 nor the TSH iAUC during the TRH stimulation test showed an association with cardiovascular risk parameters. These results therefore suggest that responsiveness by the pituitary to TRH stimulation is not involved in modulating cardiovascular risk parameters. Because studies investigating TSH release by the pituitary in response to TRH stimulation in euthyroid overweight and obese children are scarce, affirmation of our findings in other cohort studies is recommendable.
After 1-year lifestyle intervention, changes in serum TSH (but not fT4) concentrations were significantly associated with changes in cardiovascular risk parameters in children with successful weight loss. Interestingly, these changes were not just simply the consequence of the weight loss, because we here demonstrated that changes in BMI z score were not associated with changes in cardiovascular risk parameters. These findings reinforce the findings of Aeberli et al., who demonstrated that changes in serum TSH concentrations were associated with changes in metabolic risk parameters, independent of changes in body weight or composition in children and adolescents with obesity (6) . In contrast to our findings, they demonstrated an association of the change in TSH with the change in HOMA-IR (6) . This difference in findings might be explained by the difference in study design and duration of the intervention. Instead of rapid weight loss as applied by Aeberli et al. (6) , our intervention provided ongoing care and monitoring at the outpatient clinic aimed at gradual and permanent behavior changes and sustainable health benefits over time. This is in concordance with the most recent statement of the American Heart Association (34) and resulted in a gradual improvement or stabilization of cardiovascular risk parameters, even after 24-month intervention as demonstrated previously (4) . In the study population of Aeberli et al., the 2-month, inpatient rapid weight loss intervention resulted in a significant decrease in HOMA-IR by more than 50% (6) . In our study, long-term effects were evaluated in children with different puberty stages, and it is known that a physiological and transient increase in insulin resistance occurs during puberty in overweight and obese children (35) . In short-term intervention Data presented as mean 6 SD or as median (minimum to maximum). a Significant difference between baseline and after the first year of the intervention, P , 0.01.
b Significant difference between baseline and after the first year of the intervention, P , 0.05.
studies, the effect of pubertal changes is minimal, excluding these effects on HOMA-IR.
In conclusion, in euthyroid overweight and (morbidly) obese children, serum TSH concentrations are positively associated with markers representing increased CVD risk such as TC, LDL-C, TAG, and MCP-1 concentrations. The additional observation that changes in TSH are associated with changes in TC, LDL-C, and TAG concentrations in children with successful weight loss after 1 year of participating in a lifestyle intervention strengthens the earlier assumptions that serum TSH is indeed an intermediary factor in modulating lipid and lipoprotein metabolism, although causality could not be demonstrated. It is worth exploring in more depth the potential association between TSH and whole-body cholesterol metabolism, including endogenous cholesterol synthesis, intestinal cholesterol absorption, and receptor-mediated cholesterol clearance. Data represented as unstandardized regression coefficient (95% confidence interval). Linear regression models are adjusted for age. a P , 0.05.
